Star Imaging And Path Lab Ltd (STARIMAGIN)

Loading page…

Star Imaging And Path Lab Ltd (STARIMAGIN) · mywealthgrid

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Consolidated figures · ₹ crore

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	59	79	84	89
COGS	—	—	—	6
Gross profit	—	—	—	83
	22	28	24	50
	—	—	—	33
OPM %	—	—	—	37.5%
Depreciation	3	5	5	6
Interest	2	2	3	2
	0	1	0	1
Profit before tax	1	16	21	26
Tax	0	4	5	7
Tax %	34.8%	22.8%	25.6%	26.7%
	1	12	16	19
PAT margin %	1%	15.8%	19.1%	21.8%
EPS (₹)	0.4	9.2	11.8	11.1

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	2	2	14	—
Reserves	17	30	34	—
	27	31	33	—
	16	20	18	154
Total equity & liabilities	61	82	98	154
	13	22	21	25
CWIP	6	0	0	—
Investments	0	0	0	0
	42	60	77	128
Total assets	61	82	98	154

₹ Cr	Mar 2026
	23
	-13
	36
Net cash flow	46
Free cash flow	13
CFO / Operating profit %	70.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 15%
1 year: 6%

Compounded profit growth

7 years: —
5 years: —
3 years: 222%
1 year: 21%

Return on equity

7 years: —
5 years: —
3 years: 26%
Last year: 34%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	93.6%
EBITDA margin %	—	—	—	37.5%
EBIT margin %	—	—	—	30.8%
PAT margin %	1%	15.8%	19.1%	21.8%
Working capital
Receivable days	110	151	222	—
Inventory days	10	7	4	24
Payable days	—	—	—	—
NWC days	—	—	—	—
Leverage
Current ratio	1.01	1.63	1.97	4
Debt to EBITDA	—	—	—	—
Debt to equity	1.4	0.98	0.69	—
Interest coverage	-1.8	-1.8	-1.9	14.3
Asset turnover	0.96	0.96	0.85	0.58
Return ratios
Return on assets %	0.9%	15.2%	16.3%	12.6%
Return on capital employed %	-9%	-9.6%	-8.3%	29.9%
Return on equity %	3.1%	39.7%	33.8%	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Jun 2025	Sep 2025	Mar 2026
	71.92%	71.92%	71.92%
	1.18%	1.37%	0.61%
	11.44%	9.33%	5.73%
	0%	0%	0.41%
	15.46%	17.38%	21.33%
No. of shareholders	1,025	779	773

Promoter holding up 0 percentage points since Jun 2025.

Pawan GuptaManaging Director
Chhaya GuptaExecutive Director
Neelam RatraExecutive Director
Sameer SoodNon- Executive Director
Vimal GuptaIndependent Director
Yogesh Kumar VirmaniIndependent Director
Dikshant NagpalIndependent Director
Md Shadab KhanCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

10 announcementsExport CSV

30 Sept 2026, 6:15 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

29 Sept 2026, 5:17 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

28 Sept 2026, 4:24 pmCompany Update

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Commencement Of Commercial Operations Of CT Scan Facility At Faridabad, Haryana

General PDF

4 Sept 2026, 12:53 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

2 Sept 2026, 1:14 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

1 Sept 2026, 2:39 pmCompany Update

Web-Link To Access The Annual Report-2025-26

General PDF

1 Sept 2026, 2:29 pmAGM/EGM

Notice Of 22Nd Annual General Meeting (AGM) Of The Company For The Financial Year 2025-26

AGM PDF

1 Sept 2026, 2:24 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

Date	Category	Subject	Filing
30 Sept 2026, 6:15 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
29 Sept 2026, 5:17 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM

Loading announcements…

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	93.6%
EBITDA margin %	—	—	—	37.5%
EBIT margin %	—	—	—	30.8%
PAT margin %	1%	15.8%	19.1%	21.8%
Working capital
Receivable days	110	151	222	—
Inventory days	10	7	4	24
Payable days	—	—	—	—
NWC days	—	—	—	—
Leverage
Current ratio	1.01	1.63	1.97	4
Debt to EBITDA	—	—	—	—
Debt to equity	1.4	0.98	0.69	—
Interest coverage	-1.8	-1.8	-1.9	14.3
Asset turnover	0.96	0.96	0.85	0.58
Return ratios
Return on assets %	0.9%	15.2%	16.3%	12.6%
Return on capital employed %	-9%	-9.6%	-8.3%	29.9%
Return on equity %	3.1%	39.7%	33.8%	—

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Dr. Lal Path Labs Ltd.LALPATHLABLALPATHLAB	₹33,605 Cr	₹33,605 Cr	₹2,891 Cr	₹838 Cr	28.3%	₹542 Cr	18.5%	28.8%	21.6%	-79
Vijaya Diagnostic Centre LimitedVIJAYAVIJAYA	₹14,694 Cr	₹14,694 Cr	₹857 Cr	₹362 Cr	41.4%	₹187 Cr	21.3%	21.3%	19.7%	-117
Metropolis Healthcare LimitedMETROPOLISMETROPOLIS	₹11,151 Cr	₹11,169 Cr	₹1,710 Cr	₹422 Cr	24.4%	₹202 Cr	11.6%	17.3%	13.4%	-57
Thyrocare Technologies LimitedTHYROCARETHYROCARE	₹8,495 Cr	₹8,495 Cr	₹876 Cr	₹282 Cr	31.6%	₹176 Cr	19.6%	36.5%	28.8%	4
Nephrocare Health Services LimitedNEPHROPLUSNEPHROPLUS	₹6,509 Cr	₹6,589 Cr	₹999 Cr	₹227 Cr	22.7%	₹77 Cr	7.7%	17.1%	9.1%	-61
Suraksha Diagnostic LimitedSURAKSHASURAKSHA	₹1,824 Cr	₹1,826 Cr	₹325 Cr	₹102 Cr	30.7%	₹36 Cr	10.1%	16.8%	14.1%	-101
Krsnaa Diagnostics LimitedKRSNAAKRSNAA	₹1,798 Cr	₹2,332 Cr	₹815 Cr	₹218 Cr	27.4%	₹97 Cr	13.1%	13.1%	10.9%	65
3b Blackbio Dx Limited3BBLACKBIO3BBLACKBIO	₹1,416 Cr	₹1,417 Cr	₹96 Cr	₹50 Cr	52%	₹163 Cr	49.4%	25.3%	19.4%	235
One Global Service Provider LtdONEGLOBALONEGLOBAL	₹1,025 Cr	₹1,025 Cr	₹6 Cr	₹1 Cr	22.2%	₹1 Cr	17.3%	17.6%	19.5%	—
Health X Platform LimitedHEALTHXHEALTHX	₹868 Cr	₹890 Cr	₹1,468 Cr	₹-67 Cr	-4%	₹-20 Cr	-0.1%	—	0.2%	—
Gaudium Ivf And Women Health LimitedGAUDIUMIVFGAUDIUMIVF	₹797 Cr	₹820 Cr	₹104 Cr	₹38 Cr	36.1%	₹24 Cr	23.4%	23.1%	16.1%	92
Aspira Pathlab & Diagnostics LtdASPIRAASPIRA	₹135 Cr	₹136 Cr	₹22 Cr	₹4 Cr	16%	₹2 Cr	9.2%	17.5%	18.1%	16

Star Imaging And Path Lab Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Offer and rights documents

Events

No events on record

Announcements

Announcements

Offer and rights documents

No events on record

Not in the F&O segment

No fund holdings on record

Compounded sales growth

Compounded profit growth

Return on equity

Star Imaging And Path Lab Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Offer and rights documents

Events

No events on record

Announcements

Announcements

Offer and rights documents

No events on record

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

No fund holdings on record

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity